James Peyer - Feb 28, 2022 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director, 10%+ Owner
Signature
/s/ Sarah Field, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Feb 28, 2022
Transactions value $
$9,000
Form type
4
Date filed
3/1/2022, 05:55 PM
Previous filing
Feb 28, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $151 +42 +0% $3.60 5.23M Feb 28, 2022 See Footnote F1
transaction SNSE Common Stock Purchase $8.85K +2.46K +0.05% $3.60 5.23M Mar 1, 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.